Japan's Bayer Yakuhin To File For Key Eye Drug Approval This Year
This article was originally published in PharmAsia News
Executive Summary
Bayer's Japanese unit, Bayer Yakuhin, says its clinical trials for an eye drug could be ready for submission to the Health Ministry by the end of the year